QUILT-3.006

· NantCell, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QUILT-3.006, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.006 for Recurrent Medullary Thyroid Cancer [Phase 2]